Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification01:13

Seizures: Classification

2.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

969
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
969
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.1K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond FDG PET in Epilepsy: Radiotracers Targeting Neuroreceptors and Neural Proteins.

AJNR. American journal of neuroradiology·2026
Same author

A potential Adjunctive Role of 7T MRI and Amino-Acid PET in Localizing MRI-Occult Functional Pituitary Microadenomas: A Scoping Review.

AJNR. American journal of neuroradiology·2026
Same author

Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same authorSame journal

Nuclear Imaging of Epilepsy.

Neuroimaging clinics of North America·2026
Same author

7 Tesla MR Imaging for Evaluation of Epilepsy.

Neuroimaging clinics of North America·2026
Same author

MR Imaging Protocols for Epilepsy.

Neuroimaging clinics of North America·2026
Same journal

Implanted Devices for Management of Drug-Resistant Epilepsy: Background and MR Imaging Considerations.

Neuroimaging clinics of North America·2026
Same journal

Imaging of Epilepsy Surgery, Minimally Invasive Techniques, and Neuromodulation.

Neuroimaging clinics of North America·2026
Same journal

Neuroimaging and the Epilepsy Journey.

Neuroimaging clinics of North America·2026
Same journal

Clinical Functional Magnetic Resonance Imaging in Epilepsy.

Neuroimaging clinics of North America·2026
Same journal

Magnetoencephalography in Epilepsy: Role and Principles.

Neuroimaging clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.5K

General Introduction to Epilepsy.

David B Burkholder1, Brian J Burkett2, Robert E Watson3

  • 1Division of Epilepsy, Mayo Clinic, Rochester, MN, USA.

Neuroimaging Clinics of North America
|April 3, 2026
PubMed
Summary
This summary is machine-generated.

Epilepsy management involves risk stratification after initial seizures. Treatment begins with antiseizure medications, with surgery or neuromodulation considered for refractory cases.

Keywords:
Antiseizure medicationEpilepsyEpilepsy surgeryNeuromodulationSeizure

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K
Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

15.5K

Related Experiment Videos

Last Updated: Apr 5, 2026

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.5K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K
Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

15.5K

Area of Science:

  • Neurology
  • Clinical Medicine
  • Patient Management

Background:

  • Epilepsy is a prevalent neurological disorder with substantial patient impact.
  • The evaluation and management of epilepsy require dynamic, individualized approaches.
  • Effective epilepsy care necessitates timely risk stratification and treatment decisions.

Purpose of the Study:

  • To outline the current diagnostic and therapeutic strategies for epilepsy.
  • To emphasize the importance of personalized treatment in epilepsy management.
  • To detail the progression of epilepsy treatment from initial seizure to advanced therapies.

Main Methods:

  • Review of current clinical guidelines and evidence-based practices for epilepsy.
  • Analysis of risk stratification protocols following initial seizures.
  • Examination of treatment algorithms for diagnosed epilepsy, including medication and surgical options.

Main Results:

  • Initial seizure management focuses on risk assessment to guide treatment necessity.
  • Antiseizure medications are the primary treatment for diagnosed epilepsy.
  • Refractory epilepsy cases may benefit from surgical interventions or neuromodulation.

Conclusions:

  • Epilepsy treatment is tailored to individual patient factors and disease progression.
  • A stepwise approach, starting with medication and progressing to advanced therapies, is crucial.
  • Optimizing epilepsy management improves patient outcomes and quality of life.